Knockdown of FTH1P3 decreases the 50% inhibitory concentration value of paclitaxel, induces cell cycle arrest at the G2/M phase, and suppresses tumor growth of paclitaxel-resistant BC cells as well as ABCB1 protein expression in vivo [98]. This evidence concerns the gene FTH1P3 and neoplasm.